.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Healthtrust
Chubb
Johnson and Johnson
Queensland Health
McKinsey
Teva
Fish and Richardson
Novartis
Cerilliant

Generated: January 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: oxymorphone hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-609-3030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-609-30)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-609-9090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-609-90)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-609-6060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-609-60)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-747-9090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-747-90)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-747-5656 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-747-56)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-747-3030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-747-30)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-747-6060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-747-60)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-767-9090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-767-90)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-767-3030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-767-30)
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL021610NDASTAT RX USA LLC16590-767-6060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16590-767-60)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Boehringer Ingelheim
Fuji
Covington
Citi
Cantor Fitzgerald
Farmers Insurance
Fish and Richardson
Express Scripts

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot